Literature DB >> 9317143

IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb.

T Komatsu1, C S Reiss.   

Abstract

In this report, the role of IFN-gamma in host defense to exogenous IL-12 and clearance of vesicular stomatitis virus (VSV) from the central nervous system was examined. Wild-type and IFN-gamma knockout mice infected with VSV were treated with IL-12 or medium. In both groups, IL-12 treatment resulted in 1) substantially decreased VSV titers in brain homogenates and diminished immunohistochemical detection of VSV Ags in tissue sections; 2) induction of types 1, 2, and 3 nitric oxide synthase; and 3) induction of MHC molecules and rapid infiltration of both T cells and NK cells. These results suggest that IFN-gamma production, both systemically and in the olfactory bulb, contributes to but is not essential for clearance of VSV from the brain. Neutralization of TNF-alpha in IFN-gamma knockout mice mice treated with IL-12 was accompanied by the same immunohistochemical changes, implying that neither IFN-gamma nor TNF-alpha was required. In vitro studies using purified IL-12 or IFN-gamma in culture medium induced nitric oxide synthase isoforms in neurons, glia, and macrophages, and MHC II on glia and macrophages. These data suggest that IL-12 directly activates neurons to promote viral clearance in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

2.  Borna disease virus accelerates inflammation and disease associated with transgenic expression of interleukin-12 in the central nervous system.

Authors:  Susanna Freude; Jürgen Hausmann; Markus Hofer; Ngan Pham-Mitchell; Iain L Campbell; Peter Staeheli; Axel Pagenstecher
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

4.  Gene expression contributing to recruitment of circulating cells in response to vesicular stomatitis virus infection of the CNS.

Authors:  Derek D C Ireland; Carol Shoshkes Reiss
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

5.  Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.

Authors:  K K Tekkanat; H Maassab; A A Berlin; P M Lincoln; H L Evanoff; M H Kaplan; N W Lukacs
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Vesicular stomatitis viruses with rearranged genomes have altered invasiveness and neuropathogenesis in mice.

Authors:  E Brian Flanagan; Trenton R Schoeb; Gail W Wertz
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice.

Authors:  Aline Andrade de Sousa; Renata Reis; João Bento-Torres; Nonata Trévia; Nara Alves de Almeida Lins; Aline Passos; Zaire Santos; José Antonio Picanço Diniz; Pedro Fernando da Costa Vasconcelos; Colm Cunningham; Victor Hugh Perry; Cristovam Wanderley Picanço Diniz
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

8.  Intracerebral administration of interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie.

Authors:  Paolo Pasquali; Romolo Nonno; Maria Teresa Mandara; Michele Angelo Di Bari; Giovanni Ricci; Paola Petrucci; Silvia Capuccini; Claudia Cartoni; Agostino Macrì; Umberto Agrimi
Journal:  BMC Vet Res       Date:  2006-12-27       Impact factor: 2.741

9.  Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.

Authors:  Lukxmi Balathasan; Vera A Tang; Beta Yadollahi; Jan Brun; Melanie Labelle; Charles Lefebvre; Stephanie L Swift; David F Stojdl
Journal:  Mol Ther Oncolytics       Date:  2017-09-15       Impact factor: 7.200

Review 10.  The role of IL-12, IL-23 and IFN-gamma in immunity to viruses.

Authors:  Francesco Novelli; Jean-Laurent Casanova
Journal:  Cytokine Growth Factor Rev       Date:  2004-10       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.